Variant report
Variant | nsv972965 |
---|---|
Chromosome Location | chr11:25551880-25557848 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:25557121-25557458 | Hela-S3 | cervix: | n/a | n/a |
2 | FOS | chr11:25557050-25557254 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | FOS | chr11:25557044-25557245 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | POLR2A | chr11:25556137-25556204 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000265837 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566342035 | chr11:25551895-25551896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190205204 | chr11:25551904-25551905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs3864865 | chr11:25551992-25551993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548952009 | chr11:25552029-25552030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139096040 | chr11:25552042-25552043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs10834704 | chr11:25552049-25552050 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs572597488 | chr11:25552097-25552098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17242279 | chr11:25552123-25552124 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs556222232 | chr11:25552156-25552157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34417495 | chr11:25552162-25552163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76480092 | chr11:25552200-25552201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538432890 | chr11:25552209-25552210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553568708 | chr11:25552265-25552266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79128383 | chr11:25552282-25552283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542518594 | chr11:25552305-25552306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532702162 | chr11:25552317-25552318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576379748 | chr11:25552321-25552322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs12285177 | chr11:25552334-25552335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565362646 | chr11:25552345-25552346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532512591 | chr11:25552365-25552366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182418610 | chr11:25552419-25552420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186693585 | chr11:25552420-25552421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs11028754 | chr11:25552448-25552449 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs548890530 | chr11:25552450-25552451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191116021 | chr11:25552461-25552462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11028755 | chr11:25552466-25552467 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs148690434 | chr11:25552499-25552500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11028756 | chr11:25552531-25552532 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs552631567 | chr11:25552541-25552542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs553519895 | chr11:25552552-25552553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565551626 | chr11:25552557-25552558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570843145 | chr11:25552571-25552572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10767400 | chr11:25552594-25552595 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs530883593 | chr11:25552597-25552598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543761955 | chr11:25552646-25552647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558684977 | chr11:25552650-25552651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577384595 | chr11:25552675-25552676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541553378 | chr11:25552703-25552704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs10501012 | chr11:25552727-25552728 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs575064420 | chr11:25552747-25552748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11028757 | chr11:25552751-25552752 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs535269984 | chr11:25552802-25552803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs73429546 | chr11:25552866-25552867 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs61897211 | chr11:25552882-25552883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564747848 | chr11:25552886-25552887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76161560 | chr11:25552906-25552907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547071478 | chr11:25552916-25552917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565487768 | chr11:25552931-25552932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539926805 | chr11:25552933-25552934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150715574 | chr11:25552944-25552945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:25551200-25552200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr11:25552200-25553400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr11:25556200-25558200 | Enhancers | Fetal Lung | lung |
4 | chr11:25556600-25558200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr11:25556800-25558200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr11:25557200-25557400 | Enhancers | Ovary | ovary |
7 | chr11:25557200-25557600 | Enhancers | Adipose Nuclei | Adipose |
8 | chr11:25557200-25557600 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr11:25557200-25558200 | Enhancers | Fetal Stomach | stomach |
10 | chr11:25557400-25558000 | Enhancers | Brain Germinal Matrix | brain |